Aquestive Therapeutics, Inc.

NasdaqGM:AQST Stock Report

Market Cap: US$233.4m

Aquestive Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:AQST Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Nov 24SellUS$214Cassie JungIndividual44US$4.87

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AQST?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders5,806,8245.85%
General Public46,100,59646.4%
Institutions47,420,50847.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 44.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.88%
Bratton Capital Management, L.P.
9,810,958US$23.1m0%100.0%
5.98%
BlackRock, Inc.
5,935,754US$13.9m-1.05%no data
4.1%
The Vanguard Group, Inc.
4,073,558US$9.6m-6.29%no data
3.75%
Perceptive Advisors LLC
3,727,208US$8.8m0%0.32%
2.77%
Armistice Capital LLC
2,750,000US$6.5m0%0.16%
1.86%
Daniel Barber
1,847,016US$4.3m33.4%no data
1.71%
Geode Capital Management, LLC
1,700,706US$4.0m2.79%no data
1.53%
Morgan Stanley, Investment Banking and Brokerage Investments
1,524,490US$3.6m107%no data
1.53%
State Street Global Advisors, Inc.
1,522,655US$3.6m1.25%no data
1.34%
Pale Fire Capital SE
1,335,684US$3.1m154%0.32%
1.34%
Bank of America Corporation, Asset Management Arm
1,330,525US$3.1m92.8%no data
1.07%
Janney Montgomery Scott LLC, Asset Management Arm
1,059,760US$2.5m7.65%0.01%
0.99%
Alexander Schobel
984,476US$2.3m0%no data
0.93%
CHI Advisors LLC
920,000US$2.2m2.22%1.5%
0.77%
Goldman Sachs Group, Investment Banking and Securities Investments
765,388US$1.8m-11.6%no data
0.65%
Lori Braender
649,242US$1.5m36.1%no data
0.59%
Northern Trust Global Investments
587,828US$1.4m-2%no data
0.58%
Two Sigma Advisers, LP
576,400US$1.4m3,500%no data
0.5%
Harvey Capital Management Inc
499,570US$1.2m86.8%0.28%
0.46%
Citadel Advisors LLC
459,550US$1.1m20.4%no data
0.46%
Bracebridge Capital, LLC
459,216US$1.1m0%0.56%
0.41%
Woodline Partners LP
407,661US$958.0k-0.4%0.01%
0.39%
Sio Capital Management, LLC
391,629US$920.3k0%0.27%
0.38%
Stifel Asset Management Corp.
375,128US$881.6k-5.88%no data
0.37%
Two Sigma Investments, LP
372,063US$874.3k111%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/25 20:21
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aquestive Therapeutics, Inc. is covered by 11 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Gary NachmanBMO Capital Markets Equity Research
Kristen KluskaCantor Fitzgerald & Co.